Page last updated: 2024-10-30

metformin and Paraganglioma

metformin has been researched along with Paraganglioma in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Paraganglioma: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992)

Research Excerpts

ExcerptRelevanceReference
" Using unique PGL cell models established in our laboratory, we evaluated the effect of dichloroacetate (DCA) as single agent or in a novel combination with other metabolic drugs, including GW6471 and metformin."5.48Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells. ( Amoroso, R; Arduini, A; Cama, A; Cataldi, A; De Lellis, L; di Giacomo, V; Florio, R; Gallorini, M; Mariani-Costantini, R; Natale, A; Perconti, S; Sanna, M; Verginelli, F; Veschi, S, 2018)
" Using unique PGL cell models established in our laboratory, we evaluated the effect of dichloroacetate (DCA) as single agent or in a novel combination with other metabolic drugs, including GW6471 and metformin."1.48Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells. ( Amoroso, R; Arduini, A; Cama, A; Cataldi, A; De Lellis, L; di Giacomo, V; Florio, R; Gallorini, M; Mariani-Costantini, R; Natale, A; Perconti, S; Sanna, M; Verginelli, F; Veschi, S, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wang, Z1
Tao, E1
Chen, Y1
Wang, Q1
Liu, M1
Wei, L1
Xu, S1
Chen, W1
Zhong, C1
Florio, R1
De Lellis, L1
Veschi, S1
Verginelli, F1
di Giacomo, V1
Gallorini, M1
Perconti, S1
Sanna, M1
Mariani-Costantini, R1
Natale, A1
Arduini, A1
Amoroso, R1
Cataldi, A1
Cama, A1

Other Studies

2 other studies available for metformin and Paraganglioma

ArticleYear
NDUFA4 promotes the progression of head and neck paraganglioma by inhibiting ferroptosis.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 2023, Dec-01, Volume: 101, Issue:6

    Topics: Adenosine Triphosphate; Animals; Electron Transport Complex IV; Ferroptosis; Humans; Metformin; Mice

2023
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells.
    Scientific reports, 2018, 09-11, Volume: 8, Issue:1

    Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Dichloroacetic Acid; Drug Screening Assays,

2018